Evidence map›Paper›PMID 24586298›Full record

ArticlePloS one2014

Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.

Sujatha P Koduvayur, Hélène A Gussin, Rajni Parthasarathy, Zengping Hao, Brian K Kay, David R Pepperberg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Recombinant Antibodies in Basic Neuroscience Research.Current protocols in neuroscience · 2020
    Review
  3. Review
  4. Article
  5. Inhibition of duck hepatitis B virus replication by mimic peptidesExperimental and therapeutic medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sujatha P KoduvayurDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Hélène A GussinLions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Rajni ParthasarathyLions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, United States of America ; Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Zengping HaoDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Brian K KayDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, United States of America.
David R PepperbergLions of Illinois Eye Research Institute, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, United States of America ; Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Smith-Kettlewell Eye Research Institute · USUniversity of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCANANY, JAMES JASON · 1985 to 2025
$14.8M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029879 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAZZONE, THEODORE · 2009 to 2011
$11.0M
Development of Nanoscale Neuromodulating PlatformsR01EY016094 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PEPPERBERG, DAVID R · 2006 to 2010
$6.7M
Zebrafish Protein & Antibody CoreR01GM079096 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KAY, BRIAN KENNETH · 2006 to 2008
$844k
NCRR NIH HHS UL1 RR029879NEI NIH HHS EY001792NEI NIH HHS EY016094NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY016094NIGMS NIH HHS 1R01GM079096NIGMS NIH HHS R01 GM079096
6 · The paper itself

Abstract

The abundance and physiological importance of GABAA receptors in the central nervous system make this neurotransmitter receptor an attractive target for localizing diagnostic and therapeutic biomolecules. GABAA receptors are expressed within the retina and mediate synaptic signaling at multiple stages of the visual process. To generate monoclonal affinity reagents that can specifically recognize GABAA receptor subunits, we screened two bacteriophage M13 libraries, which displayed human scFvs, by affinity selection with synthetic peptides predicted to correspond to extracellular regions of the rat α1 and β2 GABAA subunits. We isolated three anti-β2 and one anti-α1 subunit specific scFvs. Fluorescence polarization measurements revealed all four scFvs to have low micromolar affinities with their cognate peptide targets. The scFvs were capable of detecting fully folded GABAA receptors heterologously expressed by Xenopus laevis oocytes, while preserving ligand-gated channel activity. Moreover, A10, the anti-α1 subunit-specific scFv, was capable of detecting native GABAA receptors in the mouse retina, as observed by immunofluorescence staining. In order to improve their apparent affinity via avidity, we dimerized the A10 scFv by fusing it to the Fc portion of the IgG. The resulting scFv-Fc construct had a Kd of ∼26 nM, which corresponds to an approximately 135-fold improvement in binding, and a lower detection limit in dot blots, compared to the monomeric scFv. These results strongly support the use of peptides as targets for generating affinity reagents to membrane proteins and encourage investigation of molecular conjugates that use scFvs as anchoring components to localize reagents of interest at GABAA receptors of retina and other neural tissues, for studies of receptor activation and subunit structure.

Indexed as

Amino Acid SequenceAnimalsAntibody SpecificityGenetic EngineeringHumansMiceMolecular Sequence DataOocytesPeptidesPichiaProtein MultimerizationProtein Structure, QuaternaryRatsReceptors, GABA-ARecombinant Fusion ProteinsRetinaPeptidesReceptors, GABA-ARecombinant Fusion ProteinsSingle-Chain Antibodies

Identifiers

PMID24586298
PMCPMC3929611
OpenAlexW2046527707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.